Net clinical benefit of non-vitamin K antagonist oral anticoagulants in atrial fibrillation and chronic kidney disease: a trade-off analysis from four phase III clinical trials

BACKGROUND: Atrial fibrillation (AF) is quite prevalent in patient with chronic kidney disease (CKD). This study mainly investigated the net clinical benefit (NCB) property of non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with AF and CKD by a pooled-analysis. METHO...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiovasc Diagn Ther
Autori principali: Gu, Zhi-Chun, Kong, Ling-Cong, Yang, Shuo-Fei, Wei, An-Hua, Wang, Na, Ding, Zheng, Zhang, Chi, Liu, Xiao-Yan, Zheng, Ying-Li, Lin, Hou-Wen
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6837910/
https://ncbi.nlm.nih.gov/pubmed/31737513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt.2019.07.09
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi